Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF vs TDF in pregnant women with chronic hepatitis B
ChiCTR2400094099Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Chronic Hepatitis B (CHB) comparing TAF antiviral group with TDF antiviral group (2 arms). Primary endpoints: HBsAg and HBeAg in infant peripheral blood, HBV-DNA in infant peripheral blood and 4 more. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tenofovir alafenamidetenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400094099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094099.